Clinical Trial Update: Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction? [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether xanthine oxidase inhibitors can reduce left ventricular hypertrophy and improve endothelial function in patients with cardiovas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Left Ventricular Hypertrophy

Drugs mentioned

• Xanthine oxidase inhibitors

Snippet

Sponsor: A. D. Struthers | Conditions: Kidney Disease, Left Ventricular Hypertrophy | Phase 4 | Status: COMPLETED